176 related articles for article (PubMed ID: 2836627)
1. Cell-mediated immunity induced in mice after vaccination with a protease activation mutant, TR-2, of Sendai virus.
Tashiro M; Fujii Y; Nakamura K; Homma M
J Virol; 1988 Jul; 62(7):2490-7. PubMed ID: 2836627
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a protease activation mutant of Sendai virus as a potent live vaccine.
Maru M; Haraguchi M; Sato K; Hotta H; Homma M
Vet Microbiol; 1992 Jan; 30(1):1-12. PubMed ID: 1311131
[TBL] [Abstract][Full Text] [Related]
3. Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide.
Kast WM; Roux L; Curren J; Blom HJ; Voordouw AC; Meloen RH; Kolakofsky D; Melief CJ
Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2283-7. PubMed ID: 1848698
[TBL] [Abstract][Full Text] [Related]
4. Aerosol vaccination with a sendai virus temperature-sensitive mutant (HVJ-pB) derived from persistently infected cells.
Iwata H; Tagaya M; Matsumoto K; Miyadai T; Yokochi T; Kimura Y
J Infect Dis; 1990 Aug; 162(2):402-7. PubMed ID: 1695654
[TBL] [Abstract][Full Text] [Related]
5. Pneumopathogenicity in mice of a Sendai virus mutant, TSrev-58, is accompanied by in vitro activation with trypsin.
Mochizuki Y; Tashiro M; Homma M
J Virol; 1988 Aug; 62(8):3040-2. PubMed ID: 2839720
[TBL] [Abstract][Full Text] [Related]
6. A protease activation mutant, MVCES1, as a safe and potent live vaccine derived from currently prevailing Sendai virus.
Wang XL; Itoh M; Hotta H; Homma M
J Virol; 1994 May; 68(5):3369-73. PubMed ID: 8151795
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic interactions of virus specific effector cells with virus infected targets of different cell type.
Koszinowski U; Ertl H
J Immunogenet; 1977 Apr; 4(2):107-14. PubMed ID: 194984
[TBL] [Abstract][Full Text] [Related]
8. Protection of mice from wild-type Sendai virus infection by a trypsin-resistant mutant, TR-2.
Tashiro M; Homma M
J Virol; 1985 Jan; 53(1):228-34. PubMed ID: 2981341
[TBL] [Abstract][Full Text] [Related]
9. Induction of CD8+ T cell responses to dominant and subdominant epitopes and protective immunity to Sendai virus infection by DNA vaccination.
Chen Y; Webster RG; Woodland DL
J Immunol; 1998 Mar; 160(5):2425-32. PubMed ID: 9498786
[TBL] [Abstract][Full Text] [Related]
10. Contributions of antibody and T cell subsets to protection elicited by immunization with a replication-defective mutant of herpes simplex virus type 1.
Morrison LA; Knipe DM
Virology; 1997 Dec; 239(2):315-26. PubMed ID: 9434723
[TBL] [Abstract][Full Text] [Related]
11. Long-term CD8+ T cell memory to Sendai virus elicited by DNA vaccination.
Chen Y; Usherwood EJ; Surman SL; Hogg TL; Woodland DL
J Gen Virol; 1999 Jun; 80 ( Pt 6)():1393-1399. PubMed ID: 10374956
[TBL] [Abstract][Full Text] [Related]
12. Efficient priming of CD8+ memory T cells specific for a subdominant epitope following Sendai virus infection.
Cole GA; Hogg TL; Coppola MA; Woodland DL
J Immunol; 1997 May; 158(9):4301-9. PubMed ID: 9126992
[TBL] [Abstract][Full Text] [Related]
13. Strict peptide length is not required for the induction of cytotoxic T lymphocyte-mediated antiviral protection by peptide vaccination.
Kast WM; Brandt RM; Melief CJ
Eur J Immunol; 1993 May; 23(5):1189-92. PubMed ID: 8386667
[TBL] [Abstract][Full Text] [Related]
14. Failure or success in the restoration of virus-specific cytotoxic T lymphocyte response defects by dendritic cells.
Kast WM; Boog CJ; Roep BO; Voordouw AC; Melief CJ
J Immunol; 1988 May; 140(9):3186-93. PubMed ID: 2834454
[TBL] [Abstract][Full Text] [Related]
15. Organ tropism of Sendai virus in mice: proteolytic activation of the fusion glycoprotein in mouse organs and budding site at the bronchial epithelium.
Tashiro M; Yamakawa M; Tobita K; Klenk HD; Rott R; Seto JT
J Virol; 1990 Aug; 64(8):3627-34. PubMed ID: 2164589
[TBL] [Abstract][Full Text] [Related]
16. Antiviral cytotoxic T-cell memory by vaccination with recombinant Listeria monocytogenes.
Slifka MK; Shen H; Matloubian M; Jensen ER; Miller JF; Ahmed R
J Virol; 1996 May; 70(5):2902-10. PubMed ID: 8627765
[TBL] [Abstract][Full Text] [Related]
17. Development of HSV-specific CD4+ Th1 responses and CD8+ cytotoxic T lymphocytes with antiviral activity by vaccination with the HSV-2 mutant ICP10DeltaPK.
Gyotoku T; Ono F; Aurelian L
Vaccine; 2002 Jun; 20(21-22):2796-807. PubMed ID: 12034107
[TBL] [Abstract][Full Text] [Related]
18. Joint recognition by cytotoxic T cells of inactivated Sendai virus and products of the major histocompatibility complex.
Schrader JW; Edelman GM
J Exp Med; 1977 Mar; 145(3):523-39. PubMed ID: 233918
[TBL] [Abstract][Full Text] [Related]
19. Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses.
Selin LK; Nahill SR; Welsh RM
J Exp Med; 1994 Jun; 179(6):1933-43. PubMed ID: 8195718
[TBL] [Abstract][Full Text] [Related]
20. Cooperation between humoral factor(s) and Lyt-2+ T cells in effective clearance of Sendai virus from infected mouse lungs.
Iwai H; Yamamoto S; Otsuka Y; Ueda K
Microbiol Immunol; 1989; 33(11):915-27. PubMed ID: 2574407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
